Dong-E-E-Jiao Co.,Ltd.

000423

CNE0000006Y9

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 18:00:00 2024-05-09 EDT			5-day change	1st Jan Change
69.09 ^CNY	-2.21%		+0.54%	+40.09%

04-25	Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-12	Dong-E-E-Jiao Forecasts Up to 55% Jump in Q1 Profit	MT

Dong-E-E-Jiao Co.,Ltd. Implements Cash Dividend for the Year 2022, Payable on June 21, 2023

June 15, 2023 at 03:32 pm

Dong-E-E-Jiao Co.,Ltd. announced implementation of (A shares) cash dividend/10 shares (tax included) of CNY 11.78093600 for the year 2022. Record date: 20 June 2023. Ex-date: 21 June 2023.

Payment date: 21 June 2023.

Latest news about Dong-E-E-Jiao Co.,Ltd.

Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-25	CI
Dong-E-E-Jiao Forecasts Up to 55% Jump in Q1 Profit	04-12	MT
Dong-E-E-Jiao's Profit Jumps 47.6% in 2023	03-22	MT
Dong-E-E-Jiao Co.,Ltd. Proposes Cash Dividend	03-21	CI
Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-21	CI
Dong-E-E-Jiao Co.,Ltd.'s Equity Buyback announced on January 2, 2024, has closed with 1,512,400 shares, representing 0.23% for CNY 75.87 million.	01-24	CI
Tranche Update on Dong-E-E-Jiao Co.,Ltd.'s Equity Buyback Plan announced on January 2, 2024.	01-24	CI
Dong-E-E-Jiao Co.,Ltd. announces an Equity Buyback for 1,660,000 shares, for CNY 124.2 million.	01-02	CI
Dong-E-E-Jiao Co.,Ltd. authorizes a Buyback Plan.	12-30	CI
Dong-E-E-Jiao's Nine-Moth Profit Rises on Higher Revenue	23-10-31	MT
Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Dong-E-E-Jiao Expects January-September Attributable Profit to Rise Up to 60%	23-10-10	MT
Dong-E-E-Jiao Co.,Ltd. Provides Earnings Guidance for the Nine Months Ended 30 September 2023	23-10-10	CI
Dong-E-E-Jiao's H1 Attributable Profit Surges 72%	23-08-06	MT
Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-06	CI
Dong-E-E-Jiao Co.,Ltd. Implements Cash Dividend for the Year 2022, Payable on June 21, 2023	23-06-15	CI
Dong-E-E-Jiao Vice President, CFO Resign	23-06-14	MT
Dong-E-E-Jiao Co.,Ltd. Approves Cash Dividend for the Year 2022	23-05-24	CI
Dong-E-E-Jiao's Q1 Profit Doubles; Shares Fall 4%	23-04-26	MT
Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25	CI
Dong-E-E-Jiao Estimates Higher Q1 Attributable Profit	23-04-13	MT
Dong-E-E-Jiao Sees Up to 114% Profit Jump in Q1	23-04-12	MT
Dong-E-E-Jiao Co.,Ltd. Proposes Dividend for the Year 2022	23-03-27	CI
Dong-E-E-Jiao Chairman Resigns	23-02-21	MT
Dong-E-E-Jiao Expects Up to 810 Million Yuan in 2022 Profit; Shares Rise 4%	23-01-30	MT

Dong-E-E-Jiao Co., Ltd. specializes in the manufacturing and marketing of Chinese traditional medicines and health products. The products are primarily for deficiencies in the blood, immunodeficiency, indigestion, insomnia and fatigue.

Sector

Pharmaceuticals

Calendar

2024-05-22 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for Dong-E-E-Jiao Co.,Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

69.09 CNY

Average target price

73.57 CNY

Spread / Average Target

+6.48%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Alternative Medicine

	1st Jan change	Capi.
DONG-E-E-JIAO CO.,LTD.	+40.09%	6.16B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-16.34%	4.46B
TASLY PHARMACEUTICAL GROUP CO., LTD	-7.11%	3.27B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+5.14%	3.2B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-0.18%	2.6B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+47.93%	1.98B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-7.15%	1.7B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+0.67%	1.66B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-8.73%	1.61B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+48.97%	1.54B

Alternative Medicine